{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:48:52Z","timestamp":1769852932095,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00380-022-02163-3","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T17:02:58Z","timestamp":1662483778000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predictive value of lipoprotein(a) for assessing the prevalence and severity of lower-extremity peripheral artery disease among patients with acute coronary syndrome"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-9745","authenticated-orcid":false,"given":"Ryo","family":"Okubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rine","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Noike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihito","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301:2331\u20132339","journal-title":"JAMA"},{"key":"2163_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","volume":"117","author":"PR Kamstrup","year":"2008","unstructured":"Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG (2008) Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population. The Copenhagen city heart study. Circulation 117:176\u2013184","journal-title":"Circulation"},{"key":"2163_CR3","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, Bennett D, Silveira A, Malarstig A, Green FR, Lathrop M, Gigante B, Leander K, de Faire U, Seedorf U, Hamsten A, Collins R, Watkins H, Farrall M (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361:2518\u20132528","journal-title":"N Engl J Med"},{"key":"2163_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2011.05.039","volume":"219","author":"P Song","year":"2011","unstructured":"Song P, Seok JM, Kim WS, Lee YT, Kim DK, Kim GM (2011) Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft. Atherosclerosis 219:285\u2013290","journal-title":"Atherosclerosis"},{"key":"2163_CR5","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","volume":"74","author":"DF Gudbjartsson","year":"2019","unstructured":"Gudbjartsson DF, Thorgeirsson G, Sulem P, Helgadottir A, Gylfason A, Saemundsdottir J, Bjornsson E, Norddahl GL, Jonasdottir A, Jonasdottir A, Eggertsson HP, Gretarsdottir S, Thorleifsson G, Indridason OS, Palsson R, Jonasson F, Jonsdottir I, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Danielsen R, Matthiasson SE, Kristmundsdottir S, Halldorsson BV, Hreidarsson AB, Valdimarsson EM, Gudnason T, Benediktsson R, Steinthorsdottir V, Thorsteinsdottir U, Holm H, Stefansson K (2019) Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes. J Am Coll Cardiol 74:2982\u20132994","journal-title":"J Am Coll Cardiol"},{"key":"2163_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2018.06.863","volume":"275","author":"EM Ooi","year":"2018","unstructured":"Ooi EM, Ellis KL, Barrett PHR, Watts GF, Hung J, Beilby JP, Thompson PL, Stobie P, McQuillan BM (2018) Lipoprotein(a) and apolipoprotein(a) isoform size: associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque. Atherosclerosis 275:232\u2013238","journal-title":"Atherosclerosis"},{"key":"2163_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22442","volume":"32","author":"D Sun","year":"2018","unstructured":"Sun D, Zhou BY, Zhao X, Li S, Zhu CG, Guo YL, Gao Y, Wu NQ, Liu G, Dong Q, Li JJ (2018) Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia. J Clin Lab Anal 32:e22442","journal-title":"J Clin Lab Anal"},{"key":"2163_CR8","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/diacare.25.5.894","volume":"25","author":"AI Adler","year":"2002","unstructured":"Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR (2002) UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894\u2013899","journal-title":"Diabetes Care"},{"key":"2163_CR9","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc16-0588","volume":"39","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Williams B, Lisheng L, Rodgers A, Mancia G, Neal B, Harrap S, Marre M, Chalmers J (2016) Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care 39:1796\u20131803","journal-title":"Diabetes Care"},{"key":"2163_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2337\/dc13-2303","volume":"37","author":"AD Althouse","year":"2014","unstructured":"Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, Mulukutla S, Aboyans V, Brooks MM (2014) Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) Trial. Diabetes Care 37:1346\u20131352","journal-title":"Diabetes Care"},{"key":"2163_CR11","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1001\/archinte.160.19.2934","volume":"160","author":"WT Meijer","year":"2000","unstructured":"Meijer WT, Grobbee DE, Hunink MG, Hofman A, Hoes AW (2000) Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 160:2934\u20132938","journal-title":"Arch Intern Med"},{"key":"2163_CR12","first-page":"e726","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Circulation 135:e726\u2013e779","journal-title":"Circulation"},{"key":"2163_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the european society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J 39:763\u2013816","journal-title":"Eur Heart J"},{"key":"2163_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-019-0955-5","volume":"18","author":"M Takahara","year":"2019","unstructured":"Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Shinke T, Amano T, Ikari Y (2019) Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases. Cardiovasc Diabetol 18:155","journal-title":"Cardiovasc Diabetol"},{"key":"2163_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW, D\u2019Agostino R Sr, Ohman EM, R\u00f6ther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197\u20131206","journal-title":"JAMA"},{"key":"2163_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","volume":"6","author":"MP Bonaca","year":"2018","unstructured":"Bonaca MP, Gutierrez JA, Cannon C, Giugliano R, Blazing M, Park JG, White J, Tershakovec A, Braunwald E (2018) Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. Lancet Diabetes Endocrinol 6:934\u2013943","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2163_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1067\/mhj.2003.6","volume":"145","author":"G Cotter","year":"2003","unstructured":"Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, Milo O, Bentley J, Blatt A, Krakover R, Zimlichman R, Reisin L, Marmor A, Lewis B, Vered Z, Caspi A, Braunwald E (2003) Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction (OPUS-TIMI) 16 study. Am Heart J 145:622\u2013627","journal-title":"Am Heart J"},{"key":"2163_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ahj.2005.11.005","volume":"151","author":"JB Froehlich","year":"2006","unstructured":"Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, L\u00f3pez-Send\u00f3n J, Allegrone J, Eagle KA, Mehta RH, Goldberg RJ (2006) Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes: the global registry of acute coronary events (GRACE). Am Heart J 151:1123\u20131128","journal-title":"Am Heart J"},{"key":"2163_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(96)90026-8","volume":"27","author":"F Kronenberg","year":"1996","unstructured":"Kronenberg F, Utermann G, Dieplinger H (1996) Lipoprotein(a) in renal disease. Am J Kidney Dis 27:1\u201325","journal-title":"Am J Kidney Dis"},{"key":"2163_CR20","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219\u2013227","journal-title":"EuroIntervention"},{"key":"2163_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2009.11.049","volume":"55","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP (2010) 5-year clinical outcomes of the ARTS II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55:1093\u20131101","journal-title":"J Am Coll Cardiol"},{"key":"2163_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ahj.2011.01.004","volume":"161","author":"M Magro","year":"2011","unstructured":"Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, van der Giessen WJ, Boersma E, van Domburg RT, van Geuns RJ, Serruys PW (2011) Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J 161:771\u2013781","journal-title":"Am Heart J"},{"key":"2163_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5551\/jat1994.5.47","volume":"5","author":"Y Matsumoto","year":"1998","unstructured":"Matsumoto Y, Daida H, Watanabe Y, Sunayama S, Mokuno H, Yokoi H, Yamaguchi H (1998) High level of lipoprotein(a) is a strong predictor for progression of coronary artery disease. J Atheroscler Thromb 5:47\u201353","journal-title":"J Atheroscler Thromb"},{"key":"2163_CR24","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"key":"2163_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412\u2013423","journal-title":"JAMA"},{"key":"2163_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"2163_CR27","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","volume":"102","author":"J Danesh","year":"2000","unstructured":"Danesh J, Collins R, Peto R (2000) Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102:1082\u20131085","journal-title":"Circulation"},{"key":"2163_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2016.01.020","volume":"246","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Cin D, Scalone G, Panebianco M, Abbolito S, Cosentino N, Jacoangeli F, Refaat H, Gallo G, Salerno G, Volpe M, Crea F, De Biase L (2016) Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease. Atherosclerosis 246:214\u2013220","journal-title":"Atherosclerosis"},{"key":"2163_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1078-5884(97)80220-1","volume":"14","author":"SW Cheng","year":"1997","unstructured":"Cheng SW, Ting AC, Wong J (1997) Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. Eur J Vasc Endovasc Surg 14:17\u201323","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2163_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","volume":"212","author":"BS Kim","year":"2010","unstructured":"Kim BS, Jung HS, Bang OY, Chung CS, Lee KH, Kim GM (2010) Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis 212:682\u2013688","journal-title":"Atherosclerosis"},{"key":"2163_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.5551\/jat.56457","volume":"28","author":"K Yanaka","year":"2021","unstructured":"Yanaka K, Akahori H, Imanaka T, Miki K, Yoshihara N, Kimura T, Tanaka T, Asakura M, Ishihara M (2021) Relationship between lipoprotein(a) and angiographic severity of femoropopliteal lesions. J Atheroscler Thromb 28:555\u2013561","journal-title":"J Atheroscler Thromb"},{"key":"2163_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1191\/1358863x03vm506ra","volume":"8","author":"RS Dieter","year":"2003","unstructured":"Dieter RS, Tomasson J, Gudjonsson T, Brown RL, Vitcenda M, Einerson J, McBride PE (2003) Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease. Vasc Med 8:233\u2013236","journal-title":"Vasc Med"},{"key":"2163_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011519","volume":"97","author":"A Saleh","year":"2018","unstructured":"Saleh A, Makhamreh H, Qoussoos T, Alawwa I, Alsmady M, Salah ZA, Shakhatreh A, Alhazaymeh L, Jabber M (2018) Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography. Medicine (Baltimore) 97:e11519","journal-title":"Medicine (Baltimore)"},{"key":"2163_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111\u2013188","journal-title":"Eur Heart J"},{"key":"2163_CR35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jcmg.2018.08.039","volume":"12","author":"S Torii","year":"2019","unstructured":"Torii S, Mustapha JA, Narula J, Mori H, Saab F, Jinnouchi H, Yahagi K, Sakamoto A, Romero ME, Narula N, Kolodgie FD, Virmani R, Finn AV (2019) Histopathologic characterization of peripheral arteries in subjects with abundant risk factors: correlating imaging with pathology. JACC Cardiovasc Imaging 12:1501\u20131513","journal-title":"JACC Cardiovasc Imaging"},{"key":"2163_CR36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S (2017) A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 69:692\u2013711","journal-title":"J Am Coll Cardiol"},{"key":"2163_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262\u20131275","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2163_CR38","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jvs.2019.03.073","volume":"70","author":"JE Wickstr\u00f6m","year":"2019","unstructured":"Wickstr\u00f6m JE, Virtanen J, Aro E, Jalkanen J, Venermo M, Hakovirta H (2019) Bilateral low systolic toe pressure and toe-brachial index are associated with long-term mortality in patients with peripheral artery disease. J Vasc Surg 70:1994\u20132004","journal-title":"J Vasc Surg"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-022-02163-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-022-02163-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-022-02163-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:09:21Z","timestamp":1672974561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-022-02163-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s00380-022-02163-3","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ikeda received a research donation from Daiichi Sankyo and received remuneration from Bayer Yakuhin and Ono Pharmaceutical. The remaining authors have no relationships to disclose that are relevant to the contents of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}